These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 9396691)

  • 21. Update on the burden of Campylobacter in developing countries.
    Platts-Mills JA; Kosek M
    Curr Opin Infect Dis; 2014 Oct; 27(5):444-50. PubMed ID: 25023741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The other Campylobacters: Not innocent bystanders in endemic diarrhea and dysentery in children in low-income settings.
    François R; Yori PP; Rouhani S; Siguas Salas M; Paredes Olortegui M; Rengifo Trigoso D; Pisanic N; Burga R; Meza R; Meza Sanchez G; Gregory MJ; Houpt ER; Platts-Mills JA; Kosek MN
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006200. PubMed ID: 29415075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Microbiological diagnosis of infections caused by Campylobacter jejuni and Campylobacter coli in humans].
    Rokosz N; Rastawicki W; Wołkowicz T
    Postepy Hig Med Dosw (Online); 2014 Jan; 68():48-56. PubMed ID: 24491895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human campylobacteriosis in developing countries.
    Coker AO; Isokpehi RD; Thomas BN; Amisu KO; Obi CL
    Emerg Infect Dis; 2002 Mar; 8(3):237-44. PubMed ID: 11927019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Campylobacter jejuni diarrhea in north Karnataka.
    Naik DG; Jayaraj YM
    Indian Pediatr; 1998 Aug; 35(8):768-70. PubMed ID: 10216571
    [No Abstract]   [Full Text] [Related]  

  • 26. Improved serological diagnosis stresses the major role of Campylobacter jejuni in triggering Guillain-Barré syndrome.
    Schmidt-Ott R; Schmidt H; Feldmann S; Brass F; Krone B; Gross U
    Clin Vaccine Immunol; 2006 Jul; 13(7):779-83. PubMed ID: 16829615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Workshop summary and recommendations regarding the development of Guillain-Barré syndrome following Campylobacter infection.
    Lang DR; Allos BM; Blaser MJ
    J Infect Dis; 1997 Dec; 176 Suppl 2():S198-200. PubMed ID: 9396711
    [No Abstract]   [Full Text] [Related]  

  • 28. Campylobacter spp in human, chickens, pigs and their antimicrobial resistance.
    Padungton P; Kaneene JB
    J Vet Med Sci; 2003 Feb; 65(2):161-70. PubMed ID: 12655109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Guillain-Barré syndrome preceded by diarrhea with the infection of Campylobacter jejuni].
    Yamada S; Bandoh M; Nagura H; Yamanouchi H; Inamatsu T
    Rinsho Shinkeigaku; 1991 Aug; 31(8):882-4. PubMed ID: 1764866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbial food borne pathogens. Campylobacter jejuni.
    Altekruse SF; Swerdlow DL; Stern NJ
    Vet Clin North Am Food Anim Pract; 1998 Mar; 14(1):31-40. PubMed ID: 9532665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A laboratory-based survey of Campylobacter infections in Prahova County.
    Sorokin M; Usein CR; Irimia M; Damian M
    Roum Arch Microbiol Immunol; 2007; 66(3-4):85-9. PubMed ID: 18928068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Fisher's syndrome following Campylobacter jejuni enteritis--a case report and review of the literature].
    Ichikawa H; Sugita K; Fukui T; Saito K; Yuki N
    Rinsho Shinkeigaku; 1995 Apr; 35(4):391-5. PubMed ID: 7614765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Campylobacteriosis of man : livestock as reservoir for Campylobacter species].
    Alter T; Bereswill S; Glünder G; Haag LM; Hänel I; Heimesaat MM; Lugert R; Rautenschlein S; Weber RM; Zautner AE; Gross U
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Jun; 54(6):728-34. PubMed ID: 21626378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Campylobacter jejuni infection and Guillain-Barré syndrome: a case-control study. Emilia-Romagna Study Group on Clinical and Epidemiological problems in neurology.
    Guarino M; Casmiro M; D'Alessandro R
    Neuroepidemiology; 1998; 17(6):296-302. PubMed ID: 9890808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Campylobacter jejuni enteritis; a review.
    Chowdhury MN
    Trop Geogr Med; 1984 Sep; 36(3):215-22. PubMed ID: 6390886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GM1 antibody in Guillain-Barre syndrome after Campylobacter jejuni infection.
    Tang J; Yuan J; Hao H
    Chin Med J (Engl); 1995 Apr; 108(4):262-4. PubMed ID: 7789212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulatory considerations for Campylobacter vaccine development.
    Kopecko DJ
    J Infect Dis; 1997 Dec; 176 Suppl 2():S189-91. PubMed ID: 9396709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
    Yuki N
    Rinsho Shinkeigaku; 1999 Jan; 39(1):17-8. PubMed ID: 10377788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of Guillain-Barré syndrome after the travel in southeast Asia--isolation of Campylobacter jejuni PEN 5 serotype].
    Koide T; Yamazaki M; Onishi Y; Saito K; Yuki N
    Rinsho Shinkeigaku; 1997 Jan; 37(1):41-3. PubMed ID: 9146072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Campylobacter jejuni infection and the Guillain-Barre syndrome: mechanisms and implications.
    Allos BM; Blaser MJ
    Zentralbl Bakteriol; 1994 Nov; 281(4):544-8. PubMed ID: 7727903
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.